bpc 157 human clinical trial evidence systematic review 2024 2025 Regeneration or Risk? A Narrative of BPC-157 for Musculoskeletal Healing High-level overview of pathways modulated
Description
Research shows this powerful treatment can combat viruses, bacteria, and fungi through its remarkable antimicrobial properties
Longer-term continuous use (6+ months) has less established safety data, though no significant concerns have emerged
Therapeutic peptides significantly reduce production of these inflammatory messengers while promoting anti-inflammatory signals
doi: 10.1016/bs.mie.2021.11.023
